Thrombosis Research Institute

Recent papers from Thrombosis Research Institute

1. Modulating atherosclerotic plaque formation by targeting plasminogen receptor PlgRKTEuropean Heart Journal · 2026
2. MicroRNAs as Diagnostic Biomarkers for Deep Vein ThrombosisDiagnostics · 2026
3. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass graftingThe Lancet · 1994
4. Explainable age prediction using a transformer trained on diverse global electrocardiogramsEuropean Heart Journal - Digital Health · 2026
5. T-cell and monocyte DNA methylation and Wnt dysregulation in common variable immunodeficiency: an exploratory studyFrontiers in Immunology · 2026
6. VLDL subfractions and risk of future venous thromboembolism – The HUNT studyThrombosis and Haemostasis · 2026
7. Integrative Omics Analysis Reveals a CD206 + Macrophage/Dendritic Cell–CD155–TIGIT + Regulatory T Cell Axis as a Protective Immune Checkpoint Pathway in Atherosclerosis ProgressionBarrier Immunity · 2026
8. Integrative multi-omics analysis reveals lipid/metabolite dysregulation and temporal decoupling in disease progressionScientific Reports · 2026
9. Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome EventNew England Journal of Medicine · 2026
10. Inflammation and hemostatic system: a selection of involved clinical disordersBleeding Thrombosis and Vascular Biology · 2026
11. Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registryEuropean Heart Journal · 2017
12. Interaction of nanoplastics with platelets: activation and fibrin clot formationFrontiers in Pharmacology · 2026
13. Effect of heparin on immunological heparin-induced thrombocytopenia-IgG chemiluminescence testingBlood Coagulation & Fibrinolysis · 2026
14. Understanding the Experiences of Young People Living With Haemophilia—A UK Social Media StudyHaemophilia · 2026
15. P2889The economic burden attributable to atrial fibrillation in nine European countries: perspectives from the GARFIELD-AF registryEuropean Heart Journal · 2018
16. Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk scoreEuropean Heart Journal · 2023
17. Calciphylaxis in chronic kidney disease: a systematic review of pathomechanisms and risk factors for calcific uremic arteriolopathyRenal Failure · 2026
18. Concomitant lipid-lowering and anticoagulation therapy for recurrent venous thromboembolism prevention: A Bayesian meta-analysisMed · 2026
19. Functional Outcomes and Safety of Endovascular Thrombectomy in Pediatric Acute Ischemic Stroke With Cardiac AbnormalitiesNeurology · 2026
20. Plasma levels of soluble Flt-1 and Tie-2 correlate with neovascularization in human carotid atherosclerotic plaques – a pilot studyFrontiers in Immunology · 2026